T2DM patients have low levels of physical activity: role of obesity

被引：1

|

作者：

Fagour, C. ^{[1
]}

Pezzino, S. ^{[2
]}

Florenty, S. ^{[2
]}

Gonzalez, C. ^{[2
]}

Rosette-Narece, M. ^{[1
]}

Gin, H. ^{[2
]}

Rigalleau, V. ^{[2
]}

机构：

[1] CHU Ft France, Fort De France, Martinique, France

[2] CHU Bordeaux, Pessac, France

来源：

DIABETES & METABOLISM | 2011年 / 37卷

关键词：

D O I：

10.1016/S1262-3636(11)70586-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A25 / A26

页数：2

相关论文

共 50 条

[41] Systemic antibacterial use increases risks of T2DM and obesity
Reactions Weekly, 2022, 1935 (1) : 11 - 11
[42] Emerging combinatorial hormone therapies for the treatment of obesity and T2DM
Sadry, Sharon A.
Drucker, Daniel J.
NATURE REVIEWS ENDOCRINOLOGY, 2013, 9 (07) : 425 - 433
[43] Identifying the Continuing Educational Needs of US Physicians in Managing Patients with T2DM and Obesity
Cerenzia, Wendy
Stacy, Sylvie
Wiley, Shereta
DIABETES, 2022, 71
[44] Risk of cardiovascular disease in patients with T2DM
Nature Reviews Endocrinology, 2013, 9 (6) : 316 - 316
[45] NAFLD prevalence in older patients with T2DM
Kotsiliti, Eleni
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023, 20 (02) : 65 - 65
[46] NAFLD prevalence in older patients with T2DM
Eleni Kotsiliti
Nature Reviews Gastroenterology & Hepatology, 2023, 20 : 65 - 65
[47] ADA goals are attainable in patients with T2DM
Hood, Robert C.
DIABETES, 2006, 55 : A271 - A271
[48] Metformin safety in T2DM patients with psoriasis
Reactions Weekly, 2019, 1743 (1) : 10 - 10
[49] Duration of Depressive Disorders in Patients with T2DM
De Groot, Mary K.
Crick, Kent
Long, Molly
Shubrook, Jay
DIABETES, 2016, 65 : A217 - A217
[50] Low plasma BDNF is not a biomarker for cognitive dysfunction in elderly T2DM patients
Ren, Qing-Guo
Chang, Jing-Hao
Lu, Wan-Jun
Gong, Wei-Gang
Zhou, Hong
NEUROLOGICAL SCIENCES, 2017, 38 (09) : 1691 - 1696

← 1 2 3 4 5 →